<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38289119</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.</ArticleTitle><Pagination><StartPage>e0150423</StartPage><MedlinePgn>e0150423</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01504-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01504-23</ELocationID><Abstract><AbstractText>Coxsackievirus B3 (CVB3) is known to cause acute myocarditis and pancreatitis in humans. We investigated the microRNAs (miRNAs) that can potentially govern the viral life cycle by binding to the untranslated regions (UTRs) of CVB3 RNA. MicroRNA-22-3p was short-listed, as its potential binding site overlapped with the region crucial for recruiting internal ribosome entry site <i>trans</i>-acting factors (ITAFs) and ribosomes. We demonstrate that miR-22-3p binds CVB3 5' UTR, hinders recruitment of key ITAFs on viral mRNA, disrupts the spatial structure required for ribosome recruitment, and ultimately blocks translation. Likewise, cells lacking miR-22-3p exhibited heightened CVB3 infection compared to wild type, confirming its role in controlling infection. Interestingly, miR-22-3p level was found to be increased at 4 hours post-infection, potentially due to the accumulation of viral 2A protease in the early phase of infection. 2A<sup>pro</sup> enhances the miR-22-3p level to dislodge the ITAFs from the SD-like sequence, rendering the viral RNA accessible for binding of replication factors to switch to replication. Furthermore, one of the cellular targets of miR-22-3p, protocadherin-1 (PCDH1), was significantly downregulated during CVB3 infection. Partial silencing of PCDH1 reduced viral replication, demonstrating its proviral role. Interestingly, upon CVB3 infection in mice, miR-22-3p level was found to be downregulated only in the small intestine, the primary target organ, indicating its possible role in influencing tissue tropism. It appears miR-22-3p plays a dual role during infection by binding viral RNA to aid its life cycle as a viral strategy and by targeting a proviral protein to restrict viral replication as a host response.IMPORTANCECVB3 infection is associated with the development of end-stage heart diseases. Lack of effective anti-viral treatments and vaccines for CVB3 necessitates comprehensive understanding of the molecular players during CVB3 infection. miRNAs have emerged as promising targets for anti-viral strategies. Here, we demonstrate that miR-22-3p binds to 5' UTR and inhibits viral RNA translation at the later stage of infection to promote viral RNA replication. Conversely, as host response, it targets PCDH1, a proviral factor, to discourage viral propagation. miR-22-3p also influences CVB3 tissue tropism. Deciphering the multifaced role of miR-22-3p during CVB3 infection unravels the necessary molecular insights, which can be exploited for novel intervening strategies to curb infection and restrict viral pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rani</LastName><ForeName>Priya</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0000-9457-5638</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Biju</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V</LastName><ForeName>Sabarishree</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biswas</LastName><ForeName>Somarghya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V</LastName><ForeName>Madhurya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pal</LastName><ForeName>Apala</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajmani</LastName><ForeName>Raju S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Saumitra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0640-3586</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Biomedical Genomics, Kalyani, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Ministry of Education, India (MoE)</Agency><Country /></Grant><Grant><Agency>University Grants Commission (UGC)</Agency><Country /></Grant><Grant><Agency>Department of Biotechnology, Ministry of Science and Technology, India (DBT)</Agency><Country /></Grant><Grant><Agency>DST | Science and Engineering Research Board (SERB)</Agency><Country /></Grant><Grant><Agency>Department of Biotechnology, Ministry of Science and Technology, India (DBT)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020121">5' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C548375">MIRN22 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C574876">Mirn22 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C081683">PCDH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C504473">Pcdh1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.29</RegistryNumber><NameOfSubstance UI="C057400">picornain 2A, Picornavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000091363">Protocadherins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020121" MajorTopicYN="Y">5' Untranslated Regions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="Y">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056189" MajorTopicYN="N">Viral Tropism</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091363" MajorTopicYN="N">Protocadherins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="Y">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076662" MajorTopicYN="Y">Host Microbial Interactions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">IRES-mediated translation</Keyword><Keyword MajorTopicYN="N">microRNAs</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38289119</ArticleId><ArticleId IdType="pmc">PMC10883805</ArticleId><ArticleId IdType="doi">10.1128/jvi.01504-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harris KG, Coyne CB. 2014. Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death. Cytokine Growth Factor Rev 25:587–596. doi:10.1016/j.cytogfr.2014.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.08.002</ArticleId><ArticleId IdType="pmc">PMC4371850</ArticleId><ArticleId IdType="pubmed">25172372</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, Shi J, McManus BM. 2015. Coxsackievirus B3 replication and pathogenesis. Future Microbiol 10:629–653. doi:10.2217/fmb.15.5</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Alirezaei M, Flynn CT, Wood MR, Whitton JL. 2012. Pancreatic acinar cell-specific autophagy disruption reduces Coxsackievirus replication and pathogenesis in vivo. Cell Host &amp; Microbe 11:298–305. doi:10.1016/j.chom.2012.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.01.014</ArticleId><ArticleId IdType="pmc">PMC3308121</ArticleId><ArticleId IdType="pubmed">22423969</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Stafford KA, Sung YK. 2012. Update on Coxsackievirus B3 myocarditis. Curr Opin Rheumatol 24:401–407. doi:10.1097/BOR.0b013e328353372d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328353372d</ArticleId><ArticleId IdType="pmc">PMC4536812</ArticleId><ArticleId IdType="pubmed">22488075</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Xiong Y, Zeng L, Peng Z, Liu Z, Zhan H, Yang Z. 2020. The role of non-coding RNAs in viral myocarditis. Front Cell Infect Microbiol 10:312. doi:10.3389/fcimb.2020.00312</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00312</ArticleId><ArticleId IdType="pmc">PMC7343704</ArticleId><ArticleId IdType="pubmed">32754448</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemida MG, Ye X, Zhang HM, Hanson PJ, Liu Z, McManus BM, Yang D. 2013. MicroRNA-203 enhances Coxsackievirus B3 replication through targeting zinc finger protein-148. Cell Mol Life Sci 70:277–291. doi:10.1007/s00018-012-1104-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1104-4</ArticleId><ArticleId IdType="pmc">PMC11113921</ArticleId><ArticleId IdType="pubmed">22842794</ArticleId></ArticleIdList></Reference><Reference><Citation>Germano JF, Sawaged S, Saadaeijahromi H, Andres AM, Feuer R, Gottlieb RA, Sin J. 2019. Coxsackievirus B infection induces the extracellular release of miR-590-5p, a proviral microRNA. Virology 529:169–176. doi:10.1016/j.virol.2019.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2019.01.025</ArticleId><ArticleId IdType="pmc">PMC6382511</ArticleId><ArticleId IdType="pubmed">30711774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, Hemida MG, Qiu Y, Hanson PJ, Zhang HM, Yang D. 2013. MiR-126 promotes Coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/β-catenin signal pathways. Cell Mol Life Sci 70:4631–4644. doi:10.1007/s00018-013-1411-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1411-4</ArticleId><ArticleId IdType="pmc">PMC11113642</ArticleId><ArticleId IdType="pubmed">23811937</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten MF, Heggermont W, Papageorgiou A-P, Deckx S, Tijsma A, Verhesen W, van Leeuwen R, Carai P, Thibaut H-J, Custers K, Summer G, Hazebroek M, Verheyen F, Neyts J, Schroen B, Heymans S. 2015. The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis. Eur Heart J 36:2909–2919. doi:10.1093/eurheartj/ehv321</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv321</ArticleId><ArticleId IdType="pubmed">26206211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D, Li M, Yu Y, Shi H, Chen R. 2019. microRNA-34a aggravates Coxsackievirus B3-induced apoptosis of cardiomyocytes through the SIRT1-p53 pathway. J Med Virol 91:1643–1651. doi:10.1002/jmv.25482</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25482</ArticleId><ArticleId IdType="pubmed">30968966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Gao X, Hu J, Xie Y, Zuo Y, Xu H, Zhu S. 2019. ADAR1p150 forms a complex with dicer to promote miRNA-222 activity and regulate PTEN expression in CVB3-induced viral myocarditis. IJMS 20:407. doi:10.3390/ijms20020407</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20020407</ArticleId><ArticleId IdType="pmc">PMC6359435</ArticleId><ArticleId IdType="pubmed">30669342</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang BY, Zhao Z, Jin Z. 2016. Expression of miR-98 in myocarditis and its influence on transcription of the FAS/FASL gene pair. Genet. Mol. Res 15. doi:10.4238/gmr.15027627</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/gmr.15027627</ArticleId><ArticleId IdType="pubmed">27323110</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Xiao Z, Yao H, Li S, Feng M, Wang W, Liu Z, Liu Z, Wu J. 2019. The protective role of microRNA-21 against Coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway. J Transl Med 17:335. doi:10.1186/s12967-019-2077-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-2077-y</ArticleId><ArticleId IdType="pmc">PMC6778380</ArticleId><ArticleId IdType="pubmed">31585536</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Yue Y, Dong C, Xiong S. 2013. MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis. Clin Invest Med 36:E103–11. doi:10.25011/cim.v36i2.19573</Citation><ArticleIdList><ArticleId IdType="doi">10.25011/cim.v36i2.19573</ArticleId><ArticleId IdType="pubmed">23544605</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Qin Y, Tong L, Wu S, Wang Q, Jiao Q, Guo Z, Lin L, Wang R, Zhao W, Zhong Z. 2012. MiR-342-5p suppresses Coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antiviral Res 93:270–279. doi:10.1016/j.antiviral.2011.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.12.004</ArticleId><ArticleId IdType="pubmed">22197249</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L, Lin L, Wu S, Guo Z, Wang T, Qin Y, Wang R, Zhong X, Wu X, Wang Y, Luan T, Wang Q, Li Y, Chen X, Zhang F, Zhao W, Zhong Z. 2013. MiR-10A* up-regulates Coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res. 41:3760–3771. doi:10.1093/nar/gkt058</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt058</ArticleId><ArticleId IdType="pmc">PMC3616696</ArticleId><ArticleId IdType="pubmed">23389951</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh DW, Gardner CL, Sun C, Haddow AD, Wang E, Chapnik E, Mildner A, Weaver SC, Ryman KD, Klimstra WB. 2014. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature 506:245–248. doi:10.1038/nature12869</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12869</ArticleId><ArticleId IdType="pmc">PMC4349380</ArticleId><ArticleId IdType="pubmed">24352241</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13:1241–1247. doi:10.1038/nm1639</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1639</ArticleId><ArticleId IdType="pubmed">17906637</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey SK, Shrinet J, Sunil S. 2019. Aedes aegypti microRNA, miR-2944B-5p interacts with 3'UTR of chikungunya virus and cellular target vps-13 to regulate viral replication. PLoS Negl Trop Dis 13:e0007429. doi:10.1371/journal.pntd.0007429</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007429</ArticleId><ArticleId IdType="pmc">PMC6576790</ArticleId><ArticleId IdType="pubmed">31166953</ArticleId></ArticleIdList></Reference><Reference><Citation>Jopling CL. 2008. Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans 36:1220–1223. doi:10.1042/BST0361220</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0361220</ArticleId><ArticleId IdType="pubmed">19021529</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador-Cañizares Y, Panigrahi M, Huys A, Kunden RD, Adams HM, Schinold MJ, Wilson JA. 2018. miR-122, small RNA annealing and sequence mutations alter the predicted structure of the hepatitis C virus 5' UTR RNA to stabilize and promote viral RNA accumulation. Nucleic Acids Res 46:9776–9792. doi:10.1093/nar/gky662</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky662</ArticleId><ArticleId IdType="pmc">PMC6182169</ArticleId><ArticleId IdType="pubmed">30053137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahal J, Gebert LFR, Gan HH, Camacho E, Gunsalus KC, MacRae IJ, Sagan SM. 2019. miR-122 and ago interactions with the HCV genome alter the structure of the viral 5' terminus. Nucleic Acids Res 47:5307–5324. doi:10.1093/nar/gkz194</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz194</ArticleId><ArticleId IdType="pmc">PMC6547439</ArticleId><ArticleId IdType="pubmed">30941417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, He Z, Jing Q, Hu Y, Lin C, Zhou R, Wang X, Su Y, Yuan J, Chen Z, Yuan J, Wu J, Li J, Zhu X, Li M. 2015. Cellular microRNA-miR-548g-3p modulates the replication of dengue virus. J Infect 70:631–640. doi:10.1016/j.jinf.2014.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2014.12.001</ArticleId><ArticleId IdType="pubmed">25499200</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu PW-C, Lin L-Z, Hsu S-D, Hsu JB-K, Huang H-D. 2007. ViTa: prediction of host microRNAs targets on viruses. Nucleic Acids Res 35:D381–5. doi:10.1093/nar/gkl1009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl1009</ArticleId><ArticleId IdType="pmc">PMC1761424</ArticleId><ArticleId IdType="pubmed">17148483</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennie W, Liu C, Carmack CS, Wolenc A, Kanoria S, Lu J, Long D, Ding Y. 2014. STarMir: a web server for prediction of microRNA binding sites. Nucleic Acids Res 42:W114–8. doi:10.1093/nar/gku376</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku376</ArticleId><ArticleId IdType="pmc">PMC4086099</ArticleId><ArticleId IdType="pubmed">24803672</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Mallick B, Long D, Rennie WA, Wolenc A, Carmack CS, Ding Y. 2013. CLIP-based prediction of mammalian microRNA binding sites. Nucleic Acids Res 41:e138. doi:10.1093/nar/gkt435</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt435</ArticleId><ArticleId IdType="pmc">PMC3737542</ArticleId><ArticleId IdType="pubmed">23703212</ArticleId></ArticleIdList></Reference><Reference><Citation>Long D, Lee R, Williams P, Chan CY, Ambros V, Ding Y. 2007. Potent effect of target structure on microRNA function. Nat Struct Mol Biol 14:287–294. doi:10.1038/nsmb1226</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1226</ArticleId><ArticleId IdType="pubmed">17401373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray PS, Das S. 2002. La autoantigen is required for the internal ribosome entry site-mediated translation of Coxsackievirus B3 RNA. Nucleic Acids Res 30:4500–4508. doi:10.1093/nar/gkf583</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkf583</ArticleId><ArticleId IdType="pmc">PMC137146</ArticleId><ArticleId IdType="pubmed">12384597</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave P, George B, Sharma DK, Das S. 2017. Polypyrimidine tract-binding protein (PTB) and PTB-associated splicing factor in CVB3 infection: an ITAF for an ITAF. Nucleic Acids Res. 45:9068–9084. doi:10.1093/nar/gkx519</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx519</ArticleId><ArticleId IdType="pmc">PMC5587786</ArticleId><ArticleId IdType="pubmed">28633417</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma B, Ponnuswamy A, Gnanasundram SV, Das S. 2011. Cryptic AUG is important for 48S ribosomal assembly during internal initiation of translation of Coxsackievirus B3 RNA. J Gen Virol 92:2310–2319. doi:10.1099/vir.0.032151-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.032151-0</ArticleId><ArticleId IdType="pubmed">21733885</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Li Y, Wang D, Wei X. 2017. miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1. Biol Res 50:27. doi:10.1186/s40659-017-0133-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40659-017-0133-8</ArticleId><ArticleId IdType="pmc">PMC5590131</ArticleId><ArticleId IdType="pubmed">28882183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Liu J, Zhang Y, Li Q, Wang Q, Gu Z. 2021. miR-22 suppresses cell viability and EMT of ovarian cancer cells via NLRP3 and inhibits Pi3K/AKT signaling pathway. Clin Transl Oncol 23:257–264. doi:10.1007/s12094-020-02413-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12094-020-02413-8</ArticleId><ArticleId IdType="pubmed">32524269</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi RU, Takata T, Shimamoto A, Ochiya T, Tahara H. 2011. miR-22 represses cancer progression by inducing cellular Senescence. J Cell Biol 193:409–424. doi:10.1083/jcb.201010100</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201010100</ArticleId><ArticleId IdType="pmc">PMC3080260</ArticleId><ArticleId IdType="pubmed">21502362</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan T, Wang CQ, Li XT, Yang H, Zhou J, Song YJ. 2021. MiR-22-3p suppresses cell migration and invasion by targeting PLAGL2 in breast cancer. J Coll Physicians Surg Pak 31:937–940. doi:10.29271/jcpsp.2021.08.937</Citation><ArticleIdList><ArticleId IdType="doi">10.29271/jcpsp.2021.08.937</ArticleId><ArticleId IdType="pubmed">34320711</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang QY, Yang KP, Li ZZ. 2020. MiR-22 restrains proliferation of rheumatoid arthritis by targeting IL6R and may be concerned with the suppression of NF-κB pathway. Kaohsiung J Med Sci 36:20–26. doi:10.1002/kjm2.12124</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/kjm2.12124</ArticleId><ArticleId IdType="pubmed">31483954</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Q, Wang X, Cai J, Du X, Sun H, Zhang N. 2020. MiR-22-3p regulates amyloid β deposit in mice model of alzheimer’s disease by targeting mitogen-activated protein kinase 14. CNR 16:473–480. doi:10.2174/1567202616666191111124516</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567202616666191111124516</ArticleId><ArticleId IdType="pubmed">31713484</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia P, Chen J, Liu Y, Cui X, Wang C, Zong S, Wang L, Lu Z. 2022. MicroRNA-22-3p ameliorates alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus. J Neuroinflammation 19:180. doi:10.1186/s12974-022-02548-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02548-1</ArticleId><ArticleId IdType="pmc">PMC9277852</ArticleId><ArticleId IdType="pubmed">35821145</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z-P, Wang D-Z. 2014. miR-22 in cardiac remodeling and disease. Trends Cardiovasc Med 24:267–272. doi:10.1016/j.tcm.2014.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2014.07.005</ArticleId><ArticleId IdType="pmc">PMC4171194</ArticleId><ArticleId IdType="pubmed">25218673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z-P, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, Wang D-Z. 2013. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 112:1234–1243. doi:10.1161/CIRCRESAHA.112.300682</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.112.300682</ArticleId><ArticleId IdType="pmc">PMC3720677</ArticleId><ArticleId IdType="pubmed">23524588</ArticleId></ArticleIdList></Reference><Reference><Citation>George B, Dave P, Rani P, Behera P, Das S. 2021. Cellular protein HuR regulates the switching of genomic RNA templates for differential functions during the Coxsackievirus B3 life cycle. J Virol 95:e0091521. doi:10.1128/JVI.00915-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00915-21</ArticleId><ArticleId IdType="pmc">PMC8513481</ArticleId><ArticleId IdType="pubmed">34406862</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Yang Q, Han J. 2022. Transcriptomic analysis reveals that Coxsackievirus B3 woodruff and GD strains use similar key genes to induce FoxO signaling pathway activation in HeLa cells. Arch Virol 167:131–140. doi:10.1007/s00705-021-05292-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05292-8</ArticleId><ArticleId IdType="pubmed">34773511</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao M, Xu C, Shen H, Liu T, Wang X, Shao C, Shao S. 2020. The regulatory role of miR-107 in Coxsackie B3 virus replication. Aging 12:14467–14479. doi:10.18632/aging.103488</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103488</ArticleId><ArticleId IdType="pmc">PMC7425430</ArticleId><ArticleId IdType="pubmed">32674073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson PJ, Hossain AR, Qiu Y, Zhang HM, Zhao G, Li C, Lin V, Sulaimon S, Vlok M, Fung G, Chen VH, Jan E, McManus BM, Granville DJ, Yang D. 2019. Cleavage and sub-cellular redistribution of nuclear pore protein 98 by Coxsackievirus B3 protease 2A impairs cardioprotection. Front Cell Infect Microbiol 9:265. doi:10.3389/fcimb.2019.00265</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00265</ArticleId><ArticleId IdType="pmc">PMC6667557</ArticleId><ArticleId IdType="pubmed">31396490</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H, Thomas P. 2009. PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol 563:123–140. doi:10.1007/978-1-60761-175-2_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60761-175-2_7</ArticleId><ArticleId IdType="pmc">PMC6608593</ArticleId><ArticleId IdType="pubmed">19597783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z, Yang Y, Wei Y, Li L, Wang X, Zhang J. 2022. Pcdh1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1. Cell Death Dis 13:633. doi:10.1038/s41419-022-05087-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-05087-y</ArticleId><ArticleId IdType="pmc">PMC9304345</ArticleId><ArticleId IdType="pubmed">35864095</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangra RK, Herbert AS, Li R, Jae LT, Kleinfelter LM, Slough MM, Barker SL, Guardado-Calvo P, Román-Sosa G, Dieterle ME, et al. . 2018. Protocadherin-1 is essential for cell entry by new world hantaviruses. Nature 563:559–563. doi:10.1038/s41586-018-0702-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0702-1</ArticleId><ArticleId IdType="pmc">PMC6556216</ArticleId><ArticleId IdType="pubmed">30464266</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C, Xu X. 2013. MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma. Biomed Pharmacother 67:375–380. doi:10.1016/j.biopha.2013.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2013.03.002</ArticleId><ArticleId IdType="pubmed">23582783</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang Y-S, Mugiyanto E, Chang W-C, Yvonne Wan Y-J. 2020. MiR-22 as a metabolic Silencer and liver tumor suppressor. Liver Res 4:74–80. doi:10.1016/j.livres.2020.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.livres.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7523703</ArticleId><ArticleId IdType="pubmed">33005474</ArticleId></ArticleIdList></Reference><Reference><Citation>Moheimani F, Koops J, Williams T, Reid AT, Hansbro PM, Wark PA, Knight DA. 2018. Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics. Respir Res 19:145. doi:10.1186/s12931-018-0851-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-018-0851-7</ArticleId><ArticleId IdType="pmc">PMC6090696</ArticleId><ArticleId IdType="pubmed">30068332</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, Du T, Wang X, Ni H, Yan Y, Li N, Zhang C, Zhang A, Gao J, Liu H, Pu F, Zhang G, Zhou E-M. 2016. Mir-22 promotes porcine reproductive and respiratory syndrome virus replication by targeting the host factor HO-1. Vet Microbiol 192:226–230. doi:10.1016/j.vetmic.2016.07.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2016.07.026</ArticleId><ArticleId IdType="pubmed">27527787</ArticleId></ArticleIdList></Reference><Reference><Citation>Morán J, Ramírez-Martínez G, Jiménez-Alvarez L, Cruz A, Pérez-Patrigeon S, Hidalgo A, Orozco L, Martínez A, Padilla-Noriega L, Avila-Moreno F, Cabello C, Granados J, Ortíz-Quintero B, Ramírez-Venegas A, Ruíz-Palacios GM, Zlotnik A, Merino E, Zúñiga J. 2015. Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection. Exp Mol Pathol 99:253–261. doi:10.1016/j.yexmp.2015.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2015.07.001</ArticleId><ArticleId IdType="pubmed">26148929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Li Q, Jia F, Zhang L, Wan S, Li Y, Song Y, Chen H, Cao S, Ye J. 2020. The Japanese encephalitis virus NS1′ protein inhibits type I IFN production by targeting MAVS. J Immunol 204:1287–1298. doi:10.4049/jimmunol.1900946</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900946</ArticleId><ArticleId IdType="pubmed">31996459</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, Ashraf U, Ye J, Duan X, Zohaib A, Wang W, Chen Z, Zhu B, Li Y, Chen H, Cao S. 2016. MicroRNA-22 negatively regulates poly(I:C)-triggered type I interferon and inflammatory cytokine production via targeting mitochondrial antiviral signaling protein (MAVS). Oncotarget 7:76667–76683. doi:10.18632/oncotarget.12395</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.12395</ArticleId><ArticleId IdType="pmc">PMC5363539</ArticleId><ArticleId IdType="pubmed">27705941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Ma X, Guo J, Mi M, Wang K, Zhang C, Tang X, Chang L, Huang Y, Tong D. 2019. Circular RNA CircEZH2 suppresses transmissible gastroenteritis coronavirus-induced opening of mitochondrial permeability transition pore via targeting MiR-22 in IPEC-J2. Int J Biol Sci 15:2051–2064. doi:10.7150/ijbs.36532</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.36532</ArticleId><ArticleId IdType="pmc">PMC6775298</ArticleId><ArticleId IdType="pubmed">31592229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadmon CS, Landers CT, Li HS, Watowich SS, Rodriguez A, King KY. 2017. MicroRNA-22 controls interferon alpha production and erythroid maturation in response to infectious stress in mice. Exp Hematol 56:7–15. doi:10.1016/j.exphem.2017.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2017.09.001</ArticleId><ArticleId IdType="pmc">PMC5696003</ArticleId><ArticleId IdType="pubmed">28911907</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M, Boroomand S, Suarez A, Si X, Rahmani M, McManus B. 2007. Coxsackievirus B3 activates nuclear factor kappa B transcription factor via a phosphatidylinositol-3 kinase/protein kinase B-dependent pathway to improve host cell viability. Cell Microbiol 9:2358–2371. doi:10.1111/j.1462-5822.2007.00964.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2007.00964.x</ArticleId><ArticleId IdType="pubmed">17848167</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Sun Z, Zhang H, Song Y, Wang Y, Xu W, Li M. 2023. CVB3 inhibits NLRP3 Inflammasome activation by suppressing NF-κB pathway and ROS production in LPS-induced macrophages. Viruses 15:1078. doi:10.3390/v15051078</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15051078</ArticleId><ArticleId IdType="pmc">PMC10222122</ArticleId><ArticleId IdType="pubmed">37243164</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S, Kopp A, Brückner V, Fechner H, Beling A. 2020. Single-point mutations within the Coxsackie B virus receptor-binding site promote resistance against soluble virus receptor traps. J Virol 94:e00952-20. doi:10.1128/JVI.00952-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00952-20</ArticleId><ArticleId IdType="pmc">PMC7495374</ArticleId><ArticleId IdType="pubmed">32669334</ArticleId></ArticleIdList></Reference><Reference><Citation>Bopegamage S, Berakova K, Gomocak P, Baksova R, Galama J, Hyoty H, Tauriainen S. 2021. Primary site of Coxsackievirus B replication in the small intestines: no proof of peyer’s patches involvement. Microorganisms 9:2600. doi:10.3390/microorganisms9122600</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9122600</ArticleId><ArticleId IdType="pmc">PMC8709031</ArticleId><ArticleId IdType="pubmed">34946201</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, et al. . 2015. Proteomics. tissue-based map of the human proteome. Science 347:1260419. doi:10.1126/science.1260419</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260419</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon JH, Srikantan S, Gorospe M. 2012. MS2-TRAP (MS2-tagged RNA affinity purification): tagging RNA to identify associated miRNAs. Methods 58:81–87. doi:10.1016/j.ymeth.2012.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2012.07.004</ArticleId><ArticleId IdType="pmc">PMC3493847</ArticleId><ArticleId IdType="pubmed">22813890</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>